Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 27% ± 9% | |
| macrophage | 11 studies | 33% ± 16% | |
| microglial cell | 9 studies | 34% ± 10% | |
| myeloid cell | 9 studies | 28% ± 12% | |
| glutamatergic neuron | 8 studies | 34% ± 22% | |
| ciliated cell | 7 studies | 23% ± 7% | |
| classical monocyte | 5 studies | 26% ± 9% | |
| neuron | 5 studies | 27% ± 10% | |
| epithelial cell | 5 studies | 32% ± 10% | |
| dendritic cell | 5 studies | 23% ± 8% | |
| GABAergic neuron | 5 studies | 38% ± 20% | |
| monocyte | 5 studies | 28% ± 8% | |
| squamous epithelial cell | 4 studies | 47% ± 19% | |
| retinal cone cell | 4 studies | 30% ± 10% | |
| astrocyte | 4 studies | 25% ± 8% | |
| basal cell | 4 studies | 28% ± 9% | |
| oligodendrocyte | 4 studies | 20% ± 5% | |
| non-classical monocyte | 3 studies | 27% ± 9% | |
| retinal rod cell | 3 studies | 16% ± 1% | |
| type I pneumocyte | 3 studies | 17% ± 2% | |
| type II pneumocyte | 3 studies | 19% ± 3% | |
| alveolar macrophage | 3 studies | 30% ± 11% | |
| endothelial cell of lymphatic vessel | 3 studies | 25% ± 6% | |
| lymphocyte | 3 studies | 24% ± 3% | |
| goblet cell | 3 studies | 31% ± 15% | |
| interneuron | 3 studies | 38% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 6003.40 | 245 / 245 | 100% | 95.11 | 502 / 502 |
| uterus | 100% | 4122.45 | 170 / 170 | 100% | 81.53 | 459 / 459 |
| esophagus | 100% | 8256.14 | 1444 / 1445 | 100% | 85.67 | 183 / 183 |
| skin | 100% | 5936.15 | 1808 / 1809 | 100% | 94.34 | 471 / 472 |
| thymus | 100% | 6805.83 | 652 / 653 | 100% | 82.98 | 604 / 605 |
| brain | 100% | 13908.53 | 2641 / 2642 | 100% | 124.37 | 703 / 705 |
| breast | 100% | 3971.81 | 457 / 459 | 100% | 82.69 | 1117 / 1118 |
| intestine | 100% | 6016.31 | 966 / 966 | 99% | 86.98 | 524 / 527 |
| kidney | 100% | 5533.22 | 89 / 89 | 99% | 62.83 | 895 / 901 |
| stomach | 100% | 5892.85 | 359 / 359 | 99% | 84.75 | 284 / 286 |
| pancreas | 100% | 4780.88 | 327 / 328 | 99% | 70.14 | 177 / 178 |
| adrenal gland | 100% | 7682.48 | 258 / 258 | 99% | 93.19 | 228 / 230 |
| lung | 99% | 6342.26 | 575 / 578 | 100% | 80.10 | 1150 / 1155 |
| bladder | 100% | 4591.14 | 21 / 21 | 99% | 71.70 | 498 / 504 |
| ovary | 99% | 2983.42 | 179 / 180 | 99% | 52.81 | 426 / 430 |
| liver | 88% | 2548.28 | 198 / 226 | 93% | 34.27 | 379 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 64.95 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 70.82 | 29 / 29 |
| spleen | 100% | 8231.06 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 101.56 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 32.63 | 1 / 1 |
| adipose | 100% | 4119.74 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4297.86 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 9328.68 | 915 / 929 | 0% | 0 | 0 / 0 |
| heart | 95% | 4491.14 | 822 / 861 | 0% | 0 | 0 / 0 |
| muscle | 95% | 2679.25 | 762 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0061077 | Biological process | chaperone-mediated protein folding |
| GO_0016079 | Biological process | synaptic vesicle exocytosis |
| GO_0045055 | Biological process | regulated exocytosis |
| GO_0051402 | Biological process | neuron apoptotic process |
| GO_0006887 | Biological process | exocytosis |
| GO_0098693 | Biological process | regulation of synaptic vesicle cycle |
| GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
| GO_0098793 | Cellular component | presynapse |
| GO_0061202 | Cellular component | clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane |
| GO_0035579 | Cellular component | specific granule membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031594 | Cellular component | neuromuscular junction |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0030672 | Cellular component | synaptic vesicle membrane |
| GO_0035577 | Cellular component | azurophil granule membrane |
| GO_0042584 | Cellular component | chromaffin granule membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005829 | Cellular component | cytosol |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0042470 | Cellular component | melanosome |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0043008 | Molecular function | ATP-dependent protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | DNAJC5 |
| Protein name | DnaJ homolog subfamily C member 5 (Ceroid-lipofuscinosis neuronal protein 4) (Cysteine string protein) (CSP) |
| Synonyms | CLN4 |
| Description | FUNCTION: Acts as a general chaperone in regulated exocytosis (By similarity). Acts as a co-chaperone for the SNARE protein SNAP-25 (By similarity). Involved in the calcium-mediated control of a late stage of exocytosis (By similarity). May have an important role in presynaptic function. May be involved in calcium-dependent neurotransmitter release at nerve endings (By similarity). . |
| Accessions | ENST00000703637.1 [Q9H3Z4-2] Q9H3Z4 ENST00000360864.9 [Q9H3Z4-1] ENST00000470551.1 [Q9H3Z4-2] |